New EU law calls for fewer use of animals in scientific research
This article was originally published in Scrip
The European Parliament has approved new legislation on animal testing that requires, among other things, EU member states to assess the animal welfare implications of each scientific experiment carried out under their jurisdiction to ensure that alternative testing methods are used when available and that painful procedures are avoided.
You may also be interested in...
Swissmedic says its good manufacturing practice certificates remain valid for longer than companies might assume. Separately, it is giving companies more time to conduct nitrosamine-related risk evaluations.
In the second segment of a two-part article on transparency provisions for the new EU clinical trial portal, a senior Merck executive explains how the company will ensure that commercially sensitive information and personal data in its clinical trial applications are not made public.
In the first of a two-part article on transparency provisions for the new EU clinical trial portal, the Pink Sheet reports on aspects that sponsors must consider to protect commercially confidential information in their clinical trial applications. The second article will look at the approach taken by Merck and discuss outstanding hot topics in relation to transparency and CTIS.